Group 1 - The core concept of surgical infection control (SIC) involves a systematic infection prevention and control system throughout the surgical process, including preoperative assessment, sterile procedures during surgery, and postoperative wound care [1][8] - The SIC industry value chain consists of upstream components like disinfection materials and medical supplies, midstream focusing on product manufacturing and service integration, and downstream connecting to various healthcare institutions [1][10] - The demand for SIC is expected to rise due to the increasing number of surgeries in China, projected at approximately 96.39 million surgeries in 2023 [11] Group 2 - The global SIC market surpassed 20 billion yuan in 2019 and is projected to reach 27.06 billion yuan by 2026, growing at an annual rate of 4-5% [2][14] - China's SIC export market has grown significantly, reaching 740 million USD in 2023, with expectations to reach 1.078 billion USD by 2026 [2][17] - Major companies in the SIC industry include Aomei Medical, Zhend Medical, Jianerkang, and Aisheren Medical, with a predominant focus on overseas sales [2][20] Group 3 - The research team from Huajing Industry Research Institute employs various analytical models to assess the SIC industry's market capacity, competitive landscape, and future trends [3][27] - The report titled "2026-2032 China Surgical Infection Control Industry Market Research and Investment Opportunity Assessment" provides insights for enterprises and investment institutions [3][27] - The SIC industry is characterized by a combination of OEM and ODM business models, with some companies transitioning to self-branded sales [2][20]